Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.03 is 57% above its 5-year average of 5.77, around the middle of its 5-year range (0.40–17.14).
As of the fiscal period ended Tuesday, June 30, 2026. 12.65% below its 12-month average of 10.34.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.03.
CURRENT RATIO
9.03
CURRENT RATIO AVG TTM
10.34
CURRENT RATIO AVG 3Y
6.93
CURRENT RATIO AVG 5Y
5.77
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.65%
CURRENT VS 3Y AVG
+30.37%
CURRENT VS 5Y AVG
+56.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.50
median of 725 covered companies
CURRENT VS SECTOR MEDIAN
+158.09%
vs the sector median at left
Market Cap
$139.73M
Current Ratio
3.96
TTM Avg
1.88
3Y Avg
1.73
5Y Avg
2.58
Market Cap
$137.19M
Current Ratio
8.73
TTM Avg
6.53
3Y Avg
6.53
5Y Avg
6.53
Market Cap
$136.86M
Current Ratio
2.72
TTM Avg
2.55
3Y Avg
3.48
5Y Avg
5.33
Market Cap
$136.15M
Current Ratio
0.79
TTM Avg
0.57
3Y Avg
0.67
5Y Avg
0.95
Market Cap
$145.21M
Current Ratio
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$145.22M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $140.25M | 9.03 | 10.34 | 6.93 | 5.77 |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 3.96 | 1.88 | 1.73 | 2.58 |
| Atrium Therapeutics, Inc. (RNA)vs › | $137.19M | 8.73 | 6.53 | 6.53 | 6.53 |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.86M | 2.72 | 2.55 | 3.48 | 5.33 |
| Freenome, Inc. (FRNM)vs › | $136.31M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $136.15M | 0.79 | 0.57 | 0.67 | 0.95 |
| Nyxoah S.A. (NYXH)vs › | $145.11M | 2.38 | 2.90 | 4.31 | 7.34 |
| Immuneering Corporation (IMRX)vs › | $145.21M | 19.47 | 11.39 | 11.91 | 15.23 |
| Korsana Biosciences, Inc. (KRSA)vs › | $145.22M | 0.82 | 5.49 | 4.19 | 4.20 |
| Pyxis Oncology, Inc. (PYXS)vs › | $134.80M | 1.34 | 5.45 | 5.41 | 6.46 |
Current Ratio
9.03
Quick Ratio
8.04
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.03 |
| 2026-03-31 | 12.64 |
| 2025-12-31 | 8.65 |
| 2025-09-30 | 6.69 |
| 2025-06-30 | 14.69 |
| 2025-03-31 | 17.14 |
| 2024-12-31 | 15.00 |
| 2024-09-30 | 1.50 |
| 2024-06-30 | 0.96 |
| 2024-03-31 | 1.32 |
| 2023-12-31 | 0.73 |
| 2023-09-30 | 0.40 |
| 2023-06-30 | 1.32 |
| 2023-03-31 | 2.04 |
| 2022-12-31 | 0.58 |
| 2022-09-30 | 1.66 |
| 2022-06-30 | 3.08 |
| 2022-03-31 | 5.29 |
| 2021-12-31 | 6.75 |
| 2021-09-30 | 5.73 |
| 2021-06-30 | 5.99 |
| 2021-03-31 | 11.57 |
| 2021-01-31 | 2.15 |
| 2020-01-31 | 0.00 |
| 2019-10-31 | 0.00 |
| 2019-07-31 | 0.00 |
| 2019-04-30 | 0.00 |
| 2019-01-31 | 0.00 |
| 2018-10-31 | 0.00 |
